Last reviewed · How we verify
Henagliflozin Proline Tablets treatment — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Henagliflozin Proline Tablets treatment (Henagliflozin Proline Tablets treatment) — Bin Lu.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Henagliflozin Proline Tablets treatment TARGET | Henagliflozin Proline Tablets treatment | Bin Lu | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Henagliflozin Proline Tablets treatment CI watch — RSS
- Henagliflozin Proline Tablets treatment CI watch — Atom
- Henagliflozin Proline Tablets treatment CI watch — JSON
- Henagliflozin Proline Tablets treatment alone — RSS
Cite this brief
Drug Landscape (2026). Henagliflozin Proline Tablets treatment — Competitive Intelligence Brief. https://druglandscape.com/ci/henagliflozin-proline-tablets-treatment. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab